期刊文献+

初诊2型糖尿病患者胰岛分泌功能及胰岛素敏感性的评估 被引量:1

Evaluation of β-cell function and insulin sensitivity in newly-diagnosed patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探索初诊2型糖尿病患者的胰岛分泌功能及胰岛素敏感性。方法185例初诊2型糖尿病患者按糖化血红蛋白水平分成4组。组1患者糖化血红蛋白水平≤8.875%、组2为8.875%~12.55%、组3为12.55%~16.225%、组4≥16.225%。比较各组初诊时的临床及生化指标特点、胰岛素分泌功能指数HOMA2-%B和胰岛素敏感指数HOMA2-%S。结果糖化血红蛋白水平较高者,其出现糖尿病典型症状的比率显著上升,酮症发病率亦上升。空腹及餐后2hC肽水平明显下降。各组HOMA2-%B呈明显下降趋势,且组间HOMA2-%S无显著差异。结论初诊2型糖尿病患者的胰岛分泌功能受损程度较其胰岛素敏感性下降更为严重,且初诊时糖化血红蛋白水平较高者,其胰岛素分泌功能下降更为显著。 Objective To investigate D-cell function and insulin sensitivity in newly-diagnosed type 2 diabetic patients. Methods Totally 185 newly diagnosed type 2 diabetic patients were divided into 4 groups according to HbAlc level: lower than 8.875%, 8.875% to 12.55%, 12.55% to 16.225%, higher than 16.225%. Clinical characteristics, biochemical parameters, HOMA2-%B and HOMA2-%S were analyzed. Results The occurrence rate of diabetic symptoms increased as HbA1c level increased, and the incidence of ketosis also increased. Fasting and postprandial 2h C-peptide levels decreased significantly. HOMA2-%B decreased in all groups, and there was no significant difference in HOMA2-%S among groups. Conclusion β-cell function decreased more severely than insulin sensitivity in newly-diagnosed type 2 diabetic patients. HOMA2-%B decreased significantly as HbAlc level increased.
出处 《世界临床药物》 CAS 2010年第2期86-88,共3页 World Clinical Drug
基金 国家自然科学基金(30700381) 上海市自然科学基金(10ZR1424100) 上海市第一人民医院院级基金(09B03)
关键词 2型糖尿病 HOMA稳态模型 胰岛素敏感性 胰岛分泌功能 type 2 diabetes mellitus HOMA homeostasis model insulin sensitivity insulin secretion function
  • 相关文献

参考文献1

二级参考文献6

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol,1979,237:E214-E223.
  • 3Li Guangwei and Pan Xiaoren. New insulin-sensitivity index for epidemiological study.Chinese Medical Journal,1995,108:55-56.
  • 4Bogardus C, Lillioja S, Howard BV, et al. Relationship between insulin secretion, insulin action and fasting plasma glucose concentration in non-insulin dependent diabetic subjects. J Clin Invest, 1984,74:1238-1246.
  • 5Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia,1985, 28:412-419.
  • 6Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab,2000, 85:2402-2410.

共引文献42

同被引文献54

  • 1Henderson JR. Why are the islets of Langerhans?[J]. Lancet, 1969, 2(7618): 469-470.
  • 2Unger RH, Orci L. The essential role of glucagon in the pathogenesis of diabetes mellitus[J]. Lancet, 1975, 1 (7897): 14-16.
  • 3Itoh N, Okamoto H. Translational control of proinsulin synthesis by glucose[J]. Nature, 1980, 283(5742): 100-102.
  • 4Welsh M, Scberberg N, Gilmore R, et al. Translational control of insulin biosynthesis. Evidence for regulation of elongation, initiation and signal- recognition-particle-mediated translational arrest by glucose[J]. Biochem J, 1986, 235(2): 459-467.
  • 5Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function[J]. Diabetes, 1993, 42(11): 1663-1672.
  • 6Butler AE, Janson J, Bonnet-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes[J]. Diabetes, 2003, 52(1): 102-110.
  • 7Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea[J]. J Clin Endocrinol Metab, 2003, 88(5): 2300-2308.
  • 8Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes[J]. J Clin Endocrinol Metab, 2001, 86(9): 4047-4058.
  • 9Grant RW, Moore AF, Florez JC. Genetic architecture of type 2 diabetes: recent progress and clinical implications[J]. Diabetes Care, 2009, 32(6): 1107-1114.
  • 10UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance[J]. Diabetologia, 1991, 34(12): 877-890.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部